Frank Klein Sells 35,558 Shares of Rocket Lab (NASDAQ:RKLB) Stock

Rocket Lab Corporation (NASDAQ:RKLB) insider Frank Klein sold 35,558 shares of Rocket Lab stock in a transaction dated Thursday, August 27th. The stock was sold at an average price of $66.61, for a total value of $2,368,518.38. Following the sale, the insider directly owned 925,737 shares of the company’s stock, valued at $61,663,341.57. This trade represents a 3.70% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Frank Klein also recently made the following trade(s):

• On Monday, August 24th, Frank Klein sold 45,692 shares of Rocket Lab stock. The shares were sold at an average price of $69.63, for a total value of $3,181,533.96.

Rocket Lab Price Performance

Shares of NASDAQ:RKLB opened at $64.39 on Friday. Rocket Lab Corporation has a twelve month low of $37.57 and a twelve month high of $151.00. The company has a current ratio of 5.48, a quick ratio of 4.98 and a debt-to-equity ratio of 0.01. The company has a market cap of $38.53 billion, a PE ratio of -238.47 and a beta of 2.60. The company’s 50 day moving average is $77.80 and its 200 day moving average is $84.98.

Rocket Lab (NASDAQ:RKLB) last announced its quarterly earnings data on Monday, August 10th. The rocket manufacturer reported ($0.08) EPS for the quarter, missing the consensus estimate of ($0.06) by ($0.02). The business had revenue of $234.07 million for the quarter, compared to analyst estimates of $231.62 million. Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. On average, sell-side analysts forecast that Rocket Lab Corporation will post -0.2 EPS for the current year.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. Deutsche Bank Aktiengesellschaft increased their target price on shares of Rocket Lab from $73.00 to $120.00 and gave the stock a “buy” rating in a research note on Tuesday, May 12th. Craig Hallum lifted their price target on Rocket Lab from $98.00 to $120.00 and gave the company a “buy” rating in a research note on Monday, June 29th. Piper Sandler started coverage on Rocket Lab in a report on Wednesday, July 15th. They issued a “neutral” rating and a $83.00 price target for the company. Morgan Stanley reiterated an “overweight” rating on shares of Rocket Lab in a research report on Wednesday, July 8th. Finally, New Street Research began coverage on Rocket Lab in a report on Wednesday, May 13th. They issued a “buy” rating and a $150.00 price objective on the stock. Three research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Rocket Lab currently has an average rating of “Moderate Buy” and a consensus target price of $110.65.

Institutional Trading of Rocket Lab

Institutional investors and hedge funds have recently modified their holdings of the stock. AQR Capital Management LLC lifted its stake in Rocket Lab by 114.0% in the 1st quarter. AQR Capital Management LLC now owns 174,308 shares of the rocket manufacturer’s stock valued at $3,117,000 after buying an additional 92,849 shares in the last quarter. NewEdge Advisors LLC increased its stake in Rocket Lab by 1,812.1% during the 1st quarter. NewEdge Advisors LLC now owns 36,807 shares of the rocket manufacturer’s stock worth $658,000 after buying an additional 34,882 shares in the last quarter. Jones Financial Companies Lllp raised its holdings in shares of Rocket Lab by 53.8% during the first quarter. Jones Financial Companies Lllp now owns 15,745 shares of the rocket manufacturer’s stock valued at $282,000 after acquiring an additional 5,507 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Rocket Lab by 13.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 773,548 shares of the rocket manufacturer’s stock valued at $13,831,000 after acquiring an additional 90,758 shares during the last quarter. Finally, Focus Partners Wealth lifted its position in shares of Rocket Lab by 1.0% in the first quarter. Focus Partners Wealth now owns 67,584 shares of the rocket manufacturer’s stock valued at $1,206,000 after acquiring an additional 681 shares in the last quarter. Hedge funds and other institutional investors own 71.78% of the company’s stock.

Rocket Lab News Summary

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Defense and space-systems demand remain important growth drivers. Rocket Lab is benefiting from its selection by Viasat to build spacecraft buses for the U.S. Space Force’s Protected Tactical SATCOM-Global program. Its HASTE hypersonic test platform is also expanding the company’s exposure to Pentagon missions, supporting the view that Rocket Lab is more than an Electron launch provider. Rocket Lab HASTE defense coverage
• Positive Sentiment: Electron execution and analyst revisions offer potential support. Rocket Lab has reached 93 Electron launches, while some analysts have raised earnings estimates. A hammer chart pattern has also prompted bottom-fishing interest after the decline. Rocket Lab bottom-fisher coverage
• Neutral Sentiment: Analysts remain broadly bullish, but the valuation requires strong execution. Rocket Lab carries a reported “Moderate Buy” consensus and an average price target of $110.65, but the company remains unprofitable and trades at a high valuation relative to current earnings. Its elevated beta also leaves the stock vulnerable to sharp swings.
• Negative Sentiment: Neutron timing is the largest operational risk. Reports that the medium-lift Neutron rocket’s first launch could slip into 2027 have weakened a key investment thesis. The delay would postpone a major revenue and valuation catalyst while extending development costs. Rocket Lab Neutron timeline coverage
• Negative Sentiment: Insider selling adds to near-term pressure. Five executives sold approximately $5.5 million of shares, including sizable sales by the CFO and COO. The transactions were made under Rule 10b5-1 plans to cover tax withholding on vested restricted stock units, reducing their significance, though no comparable insider buying was reported. Rocket Lab executive sale coverage
• Negative Sentiment: Profitability remains a concern. Rocket Lab’s latest quarterly revenue exceeded expectations, but its $0.08-per-share loss was wider than forecast. Continued annual losses make the stock particularly sensitive to acquisition uncertainty, Neutron delays, and any slowdown in launch or defense growth.

About Rocket Lab

Rocket Lab is an aerospace company that provides launch services, spacecraft, and space systems for commercial and government customers. The company’s primary launch vehicle is Electron, a small-lift orbital rocket designed to deploy small satellites and rideshare payloads to low Earth orbit. Rocket Lab also develops and manufactures the Rutherford engine, noted for its electric-pump-fed design and additive-manufactured components, which powers Electron and supports the company’s propulsion capabilities.